Literature DB >> 24908394

Clinical evaluation of 292 Genesis II posterior stabilized high-flexion total knee arthroplasty: range of motion and predictors.

Mathijs C H W Fuchs1, Rob P A Janssen.   

Abstract

The primary aim of the study was to evaluate the range of motion and complications after Genesis II total knee arthroplasty with high-flexion tibia insert (TKA-HF). Furthermore, difference in knee flexion between high flexion and standard inserts was compared. The hypothesis was that knee flexion is better after high-flexion TKA. A total of 292 TKA-HF were retrospectively reviewed. Mean follow-up was 24.3 months. The range of motion was compared between TKA-HF (high-flexion group) and a comparable cohort of 86 Genesis II TKA with a standard tibia insert (control group). Surgeries were performed by one experienced knee orthopedic surgeon. Knee flexion in the high-flexion group increased from 114.8° preoperatively to 118.0° postoperatively (P < 0.01). Knee extension in the high-flexion group increased from -4.5° preoperatively to -0.4° after surgery (P < 0.01). Mean knee flexion was 5.52° (± 1.46°) better in the high-flexion group compared with the control group (P < 0.01). Preoperative range of motion, body mass index, diabetes mellitus and patellofemoral pain significantly influenced range of motion. Few complications occurred after TKA-HF. The Genesis II TKA-HF showed good short-term results with limited complications. Knee flexion after Genesis II TKA-HF was better compared with a standard tibia insert.

Entities:  

Mesh:

Year:  2014        PMID: 24908394     DOI: 10.1007/s00590-014-1467-3

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  28 in total

Review 1.  Does the new generation of high-flex knee prostheses improve the post-operative range of movement?: a meta-analysis.

Authors:  R Mehin; R S Burnett; P M A Brasher
Journal:  J Bone Joint Surg Br       Date:  2010-10

2.  Complications after total knee arthroplasty: a comprehensive report.

Authors:  Petra Frosch; Jens Decking; Christoph Theis; Philipp Drees; Carsten Schoellner; Anke Eckardt
Journal:  Acta Orthop Belg       Date:  2004-12       Impact factor: 0.500

3.  [Ligament instability in total knee arthroplasty--causal analysis].

Authors:  H Graichen; M Strauch; T Katzhammer; L Zichner; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2007-07       Impact factor: 1.087

4.  Spontaneous late dislocation of the high flexion tibial insert after Genesis II total knee arthroplasty. A case report.

Authors:  S G M Rutten; R P A Janssen
Journal:  Knee       Date:  2009-03-04       Impact factor: 2.199

5.  High-flexion implants in primary total knee arthroplasty: a meta-analysis.

Authors:  Rajiv Gandhi; Peggy Tso; J Roderick Davey; Nizar N Mahomed
Journal:  Knee       Date:  2008-09-11       Impact factor: 2.199

6.  Complications and functional outcomes after total hip arthroplasty and total knee arthroplasty: results from the Global Orthopaedic Registry (GLORY).

Authors:  Fred Cushner; Giancarlo Agnelli; Gordon FitzGerald; David Warwick
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2010-09

Review 7.  Results of prospective, randomized clinical trials comparing standard and high-flexion posterior-stabilized TKA: a focused review.

Authors:  William G Hamilton; Supatra Sritulanondha; C Anderson Engh
Journal:  Orthopedics       Date:  2011-09-09       Impact factor: 1.390

8.  Factors affecting range of flexion after total knee arthroplasty.

Authors:  H Kawamura; R B Bourne
Journal:  J Orthop Sci       Date:  2001       Impact factor: 1.601

9.  The role of polyethylene design on postoperative TKA flexion: an analysis of 1534 cases.

Authors:  Richard W McCalden; Steven J MacDonald; Kory D J Charron; Robert B Bourne; Douglas D Naudie
Journal:  Clin Orthop Relat Res       Date:  2010-01       Impact factor: 4.176

10.  Factors affecting outcome after total knee arthroplasty in patients with diabetes mellitus.

Authors:  Hong Kyo Moon; Chang Dong Han; Ick Hwan Yang; Bong Soo Cha
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.